Status:
COMPLETED
Comparison of Tamsulosin and Solifenacin in Treatment of Ureteral Stent Symptoms
Lead Sponsor:
Mansoura University
Conditions:
Relieve of Ureteral Stent Symptoms
Eligibility:
All Genders
20-50 years
Phase:
PHASE4
Brief Summary
This study will be conducted to compare the effectiveness of alpha blocker (Tamsulosin) and Anticholinergic (Solifenacin) in relieving lower urinary tract symptoms caused DJ ureteral stents.
Detailed Description
Eligible patients who signed the informed consent will randomly assigned to one of 3 groups; group 1 (control), group 2 (tamsulosin) and group 3 (Solifenacin). Ureteral stent symptom questionnaire (US...
Eligibility Criteria
Inclusion
- Patient who will undergo unilateral ureteral stent fixation:
- To relieve upper urinary tract obstruction caused by ureteric calculi
- After ureteroscopic lithotripsy for ureteral calculi.
Exclusion
- Patients who had LUTS before stent fixation.
- Ureteral stent fixation after open or laparoscopic surgery.
- Bilateral ureteral stents.
- Patients who developed complications related to the primary endoscopic procedure
- Patients who developed stent related complications such as hematuria, acute pyelonephritis or stent displacement
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
131 Patients enrolled
Trial Details
Trial ID
NCT01880619
Start Date
January 1 2013
End Date
July 1 2014
Last Update
November 25 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Urology and Nephrology Center
Al Mansurah, Egypt, 35516